secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001516551-24-000091
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience stockholders approve amended omnibus incentive plan, increasing share pool by 1.54M
--------------------------------------------------------------------------------

- Stockholders voted 17.4M for, 6.2M against to approve the Amended and Restated Omnibus Incentive Plan.
- Plan increases authorized shares by 1,535,655 and raises incentive stock option limit to 4,000,000.
- Plan expiration extended to September 10, 2034; automatic share replenishment feature retained.
- Approval became effective upon stockholder vote at Special Meeting on October 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655124000091/0001516551-24-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655124000091/skye-20241022.htm
  HTML page:      https://secwatch.observer/filing/0001516551-24-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer